Pharmaceutical Executive Europe IMS Health Economics Supplement - December 2007 - (Page 2) ARE YOU DEMONSTRATING TRUE PRODUCT VALUE? THE BEST WAY TO KNOW. ASK IMS. We can support you. Providing your therapy’s cost effectiveness and evidence based outcomes is a “must do”. IMS taps the expertise and objectivity of over 170 specialists in health economics and outcomes around the globe. And draws on the world’s most extensive claims, medical, hospital and pharmaceutical databases. So you can make your case in each country conclusively—and leverage it globally. We welcome the tough questions. Because only IMS has the full complement of information… analytics… and consulting. By combining our global perspective with local sensibilities—from over 100 markets—we bring you knowledge-based solutions for a competitive edge. CONTACT US AT netinfo@uk.imshealth.com www.imshealth.com/ask TM © 2007 IMS Health Incorporated or its affiliates. All rights reserved. http://www.imshealth.com/ask http://www.imshealth.com/ask
Table of Contents Feed for the Digital Edition of Pharmaceutical Executive Europe IMS Health Economics Supplement - December 2007 Pharmaceutical Executive Europe IMS Health Economics Supplement - December 2007 Contents Budget Impact Analyses: BIAs: The Fifth Hurdle? Evidence and Effectiveness: Redressing the Balance Commercializing HEOR: Adding Value Pharmaceutical Executive Europe IMS Health Economics Supplement - December 2007 Pharmaceutical Executive Europe IMS Health Economics Supplement - December 2007 - Pharmaceutical Executive Europe IMS Health Economics Supplement - December 2007 (Page 1) Pharmaceutical Executive Europe IMS Health Economics Supplement - December 2007 - Pharmaceutical Executive Europe IMS Health Economics Supplement - December 2007 (Page 2) Pharmaceutical Executive Europe IMS Health Economics Supplement - December 2007 - Contents (Page 3) Pharmaceutical Executive Europe IMS Health Economics Supplement - December 2007 - Budget Impact Analyses: BIAs: The Fifth Hurdle? (Page 4) Pharmaceutical Executive Europe IMS Health Economics Supplement - December 2007 - Budget Impact Analyses: BIAs: The Fifth Hurdle? (Page 5) Pharmaceutical Executive Europe IMS Health Economics Supplement - December 2007 - Budget Impact Analyses: BIAs: The Fifth Hurdle? (Page 6) Pharmaceutical Executive Europe IMS Health Economics Supplement - December 2007 - Evidence and Effectiveness: Redressing the Balance (Page 7) Pharmaceutical Executive Europe IMS Health Economics Supplement - December 2007 - Evidence and Effectiveness: Redressing the Balance (Page 8) Pharmaceutical Executive Europe IMS Health Economics Supplement - December 2007 - Commercializing HEOR: Adding Value (Page 9) Pharmaceutical Executive Europe IMS Health Economics Supplement - December 2007 - Commercializing HEOR: Adding Value (Page 10)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.